Baidu
map

Nature:控制疟疾的灭蚊大计要考虑蚊子的遗传多样性

2017-12-05 佚名 Nature自然科研

本周《自然》在线发表的一项研究Genetic diversity of the African malaria vector Anopheles gambiae介绍了它们的遗传多样性。在分子水平上增进对这些物种的遗传学理解,对于最大程度延长杀虫剂的效用期限、加快制定新的传病媒介控制策略至关重要。

冈比亚按蚊和Coluzzii按蚊是非洲主要的疟疾传播者,本周《自然》在线发表的一项研究Genetic diversity of the African malaria vector Anopheles gambiae介绍了它们的遗传多样性。在分子水平上增进对这些物种的遗传学理解,对于最大程度延长杀虫剂的效用期限、加快制定新的传病媒介控制策略至关重要。

通过采用杀虫剂干预手段,疟疾的发病率和死亡率已经大幅下降,但是蚊子种群不断上升的杀虫剂抗性和其它适应性变化恐将令这些成绩得而复失。

英国惠康基金会桑格协会的Alistair Miles及同事参与了冈比亚按蚊1000基因组项目(Anopheles gambiae 1000 Genome Project),他们对冈比亚按蚊和Coluzzii按蚊的765个样本进行基因组测序。这些样本来自8个非洲国家的15个地点,涵盖雨林、大草原和沿海生物群区等一系列生态。

作者发现单个蚊子的基因组携带170万-270万个变异等位基因,证明它们属于最具遗传多样性的真核物种。他们还在多个已知会影响杀虫剂抗性的基因中发现了最新的正向选择信号。例如,Vgsc基因的一种突变(名为“kdr”)会降低蚊子对杀虫剂DDT和拟除虫菊酯的易感性。

作者认为在设计蚊子防控策略时应将蚊子种群较高的遗传多样性考虑在内。

原始出处:

The Anopheles gambiae 1000 Genomes Consortium.Genetic diversity of the African malaria vector Anopheles gambiae.Nature.29 November 2017.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1882682, encodeId=79a4188268263, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Apr 30 23:58:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648705, encodeId=38701648e0540, content=<a href='/topic/show?id=80a195082c4' target=_blank style='color:#2F92EE;'>#遗传多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95082, encryptionId=80a195082c4, topicName=遗传多样性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f723650071, createdName=ay2008fy, createdTime=Wed Aug 08 01:58:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470920, encodeId=b5ef14e0920e3, content=<a href='/topic/show?id=507043296fe' target=_blank style='color:#2F92EE;'>#多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43296, encryptionId=507043296fe, topicName=多样性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6a7095267, createdName=neurosurgeon, createdTime=Thu Dec 07 05:58:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267373, encodeId=b0c426e37371, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Dec 06 23:24:20 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267090, encodeId=ac8c26e090c1, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Dec 05 22:49:48 CST 2017, time=2017-12-05, status=1, ipAttribution=)]
    2018-04-30 一叶知秋
  2. [GetPortalCommentsPageByObjectIdResponse(id=1882682, encodeId=79a4188268263, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Apr 30 23:58:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648705, encodeId=38701648e0540, content=<a href='/topic/show?id=80a195082c4' target=_blank style='color:#2F92EE;'>#遗传多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95082, encryptionId=80a195082c4, topicName=遗传多样性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f723650071, createdName=ay2008fy, createdTime=Wed Aug 08 01:58:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470920, encodeId=b5ef14e0920e3, content=<a href='/topic/show?id=507043296fe' target=_blank style='color:#2F92EE;'>#多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43296, encryptionId=507043296fe, topicName=多样性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6a7095267, createdName=neurosurgeon, createdTime=Thu Dec 07 05:58:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267373, encodeId=b0c426e37371, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Dec 06 23:24:20 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267090, encodeId=ac8c26e090c1, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Dec 05 22:49:48 CST 2017, time=2017-12-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1882682, encodeId=79a4188268263, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Apr 30 23:58:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648705, encodeId=38701648e0540, content=<a href='/topic/show?id=80a195082c4' target=_blank style='color:#2F92EE;'>#遗传多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95082, encryptionId=80a195082c4, topicName=遗传多样性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f723650071, createdName=ay2008fy, createdTime=Wed Aug 08 01:58:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470920, encodeId=b5ef14e0920e3, content=<a href='/topic/show?id=507043296fe' target=_blank style='color:#2F92EE;'>#多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43296, encryptionId=507043296fe, topicName=多样性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6a7095267, createdName=neurosurgeon, createdTime=Thu Dec 07 05:58:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267373, encodeId=b0c426e37371, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Dec 06 23:24:20 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267090, encodeId=ac8c26e090c1, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Dec 05 22:49:48 CST 2017, time=2017-12-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1882682, encodeId=79a4188268263, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Apr 30 23:58:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648705, encodeId=38701648e0540, content=<a href='/topic/show?id=80a195082c4' target=_blank style='color:#2F92EE;'>#遗传多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95082, encryptionId=80a195082c4, topicName=遗传多样性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f723650071, createdName=ay2008fy, createdTime=Wed Aug 08 01:58:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470920, encodeId=b5ef14e0920e3, content=<a href='/topic/show?id=507043296fe' target=_blank style='color:#2F92EE;'>#多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43296, encryptionId=507043296fe, topicName=多样性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6a7095267, createdName=neurosurgeon, createdTime=Thu Dec 07 05:58:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267373, encodeId=b0c426e37371, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Dec 06 23:24:20 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267090, encodeId=ac8c26e090c1, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Dec 05 22:49:48 CST 2017, time=2017-12-05, status=1, ipAttribution=)]
    2017-12-06 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1882682, encodeId=79a4188268263, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Mon Apr 30 23:58:00 CST 2018, time=2018-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1648705, encodeId=38701648e0540, content=<a href='/topic/show?id=80a195082c4' target=_blank style='color:#2F92EE;'>#遗传多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95082, encryptionId=80a195082c4, topicName=遗传多样性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f723650071, createdName=ay2008fy, createdTime=Wed Aug 08 01:58:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470920, encodeId=b5ef14e0920e3, content=<a href='/topic/show?id=507043296fe' target=_blank style='color:#2F92EE;'>#多样性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43296, encryptionId=507043296fe, topicName=多样性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b6a7095267, createdName=neurosurgeon, createdTime=Thu Dec 07 05:58:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267373, encodeId=b0c426e37371, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Dec 06 23:24:20 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267090, encodeId=ac8c26e090c1, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Dec 05 22:49:48 CST 2017, time=2017-12-05, status=1, ipAttribution=)]
    2017-12-05 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0

相关资讯

Lancet Infect Dis:“超级疟疾”在东南亚蔓延

越南、泰国和英国研究人员在新一期英国《柳叶刀—传染病》杂志上刊文说,令主流疗法失效的“超级疟疾”正在东南亚传播,柬埔寨、泰国、缅甸、老挝和越南都已经出现疫情。研究人员警告,如不能得到有效控制,“超级疟疾”可能会进一步扩散传播。

疟疾快速诊断测试存矫枉过正之嫌

本世纪初,研究人员开发了针对重要的儿童杀手——疟疾的快速诊断测试(RDT)。这种方法像家用验孕工具一样简单,只需要手指上的一滴血便可检测疟原虫。RDT使非洲和亚洲偏远乡村的卫生工作人员得以准确并且几乎马上诊断疟疾,从而减少其过度使用新一代“神丹妙药”——以青蒿素为基础的联合疗法(ACT)的可能性。ACT面临着出现耐药性的危险。

西双版纳实现消除疟疾目标

11月14日,云南省卫生计生委在官方网站上发布消息称,经专家考核评估,西双版纳州已达到省级消除疟疾考核评估标准,该州作为云南省疟疾重灾区提前实现消除疟疾目标。

Lancet glob health:妊娠期患疟疾与死产的定量关联。

全球每年有260万例死产。而妊娠时患疟疾与死产的关联尚未完全量化。现Kerryn A Moore等人致力于量化这一关联,并评估疟疾的地方性对这一关联的影响。

Lancet Infect Dis:抗疟新药来了 堪比一线治疗

根据发表在《The Lancet Infectious Diseases》最新的来自FDA(美国食品和药物管理局)监督临床试验的结果显示,杜兰大学的研究人员已经开发了一种能够对抗疟疾非重症病例的新药。

Science:肠道共生菌阻断蚊子传播疟疾新策略

王四宝等发现能在按蚊中进行持续跨代传播的新共生细菌,能高效驱动抗疟效应分子快速散播到整个蚊群中,使按蚊成为无效的疟疾媒介,实现从源头上阻断疟疾传播。

Baidu
map
Baidu
map
Baidu
map